Evidence map›Paper›PMID 35710735›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Evaluation of (

Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R Emery, Hong Gao, Jim Ropchan, Achi Haider, Gilles Tamagnan and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Development and Validation of [Pharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Hazem AhmedInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Ming-Qiang ZhengPET Center, Yale University, New Haven, Connecticut; and.
Kelly SmartPET Center, Yale University, New Haven, Connecticut; and.
Hanyi FangPET Center, Yale University, New Haven, Connecticut; and.
Li ZhangPET Center, Yale University, New Haven, Connecticut; and.
Paul R EmeryPET Center, Yale University, New Haven, Connecticut; and.
Hong GaoPET Center, Yale University, New Haven, Connecticut; and.
Jim RopchanPET Center, Yale University, New Haven, Connecticut; and.
Achi HaiderInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
Gilles TamagnanPET Center, Yale University, New Haven, Connecticut; and.
Richard E CarsonPET Center, Yale University, New Haven, Connecticut; and.
Simon M AmetameyInstitute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland; henry.huang@yale.edu simon.ametamey@pharma.ethz.ch.
Yiyun HuangPET Center, Yale University, New Haven, Connecticut; and henry.huang@yale.edu simon.ametamey@pharma.ethz.ch.
Yale Cancer Center · USYale University · USETH Zurich · CH

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
A Program for Innovative PET Radioligand Development and Application - A Translational Toolbox for Treatments for Mental HealthU01MH107803 · NIMH · YALE UNIVERSITY · PI Richard E. Carson, YIYUN HENRY HUANG · 2015 to 2026
$13.7M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS U01 MH107803
6 · The paper itself

Abstract

Despite 2 decades of research, no

Indexed as

RadiopharmaceuticalsReceptors, N-Methyl-D-AspartateAnimalsBrainFluorine RadioisotopesLigandsMacaca mulattaPositron-Emission TomographyFluorine-18Fluorine RadioisotopesLigandsRadiopharmaceuticalsReceptors, N-Methyl-D-Aspartatebrain PET imagingGluN2B subunitneurodegenerationNMDAnonhuman primates

Identifiers

PMID35710735
PMCPMC9730915
OpenAlexW4282978294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.